Gasdermin D. (GSDMD) is a new promising biomarker: overexpression in the tumor is linked with aggressive clinical behavior and poor pathological features, and its expression has been recently identified as an independent survival prognosis factor [78]. This evidence concerns the gene GSDMD and neoplasm.